Current treatment of systemic sclerosis-associated interstitial lung disease

被引：1

作者：

Bes, Cemal ^{[1
]}

Cetinkaya, Erdogan ^{[2
]}

机构：

[1] Univ Hlth Sci, Basaksehir Cam & Sakura City Hosp, Dept Rheumatol, Istanbul, Turkey

[2] Univ Hlth Sci, Yedikule Chest Dis & Chest Surg Training & Res Ho, Dept Chest Dis, Istanbul, Turkey

来源：

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX | 2022年 / 70卷 / 01期

关键词：

Systemic sclerosis; interstitial lung disease; treatment; STEM-CELL TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; PULMONARY-FIBROSIS; DOUBLE-BLIND; TYROSINE KINASES; OPEN-LABEL; SCLERODERMA; CYCLOPHOSPHAMIDE; EXPERIENCE; SURVIVAL;

D O I：

10.5578/tt.20229910

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Systemic sclerosis (SSc) is a connective tissue disease characterized by immune irregularity, vasculopathy and excessive collagen production, which causes skin and internal organ fibrosis. Although SSc often affects multiple organs and/or systems, lung involvement and especially interstitial lung disease (ILD) are the leading cause of death in this disease. The fact that different treatment options have been raised in recent years has given hope to clinicians in the management of this disease. This article will also review the current treatment options of SSc-ILD.

引用

页码：85 / 92

页数：8

共 60 条

[1] Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease-a randomised controlled trial [J].

Acharya, Nupoor ;

Sharma, Shefali Khanna ;

Mishra, Debashish ;

Dhooria, Sahajal ;

Dhir, Varun ;

Jain, Sanjay .

RHEUMATOLOGY INTERNATIONAL, 2020, 40 (05) :703-710

[2] IMPROVED PULMONARY-FUNCTION IN SYSTEMIC-SCLEROSIS AFTER TREATMENT WITH CYCLOPHOSPHAMIDE [J].

AKESSON, A ;

SCHEJA, A ;

LUNDIN, A ;

WOLLHEIM, FA .

ARTHRITIS AND RHEUMATISM, 1994, 37 (05) :729-735

[3] Survival of Adults With Systemic Sclerosis Following Lung Transplantation A Nationwide Cohort Study [J].

Bernstein, Elana J. ;

Peterson, Eric R. ;

Sell, Jessica L. ;

D'Ovidio, Frank ;

Arcasoy, Selim M. ;

Bathon, Joan M. ;

Lederer, David J. .

ARTHRITIS & RHEUMATOLOGY, 2015, 67 (05) :1314-1322

[4] Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis [J].

Bosello, Silvia L. ;

De Luca, Giacomo ;

Rucco, Manuela ;

Berardi, Giorgia ;

Falcione, Matteo ;

Danza, Francesco Maria ;

Pirronti, Tommaso ;

Ferraccioli, Gianfranco .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (04) :428-436

[5] Therapeutic Inhibition of Tyrosine Kinases in Systemic Sclerosis: A Review of Published Experience on the First 108 Patients Treated with Imatinib [J].

Bournia, Vasiliki-Kalliopi ;

Evangelou, Konstantinos ;

Sfikakis, Petros P. .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2013, 42 (04) :377-390

[6] Lung Transplant in Patients with Scleroderma Compared with Pulmonary Fibrosis Short- and Long-Term Outcomes [J].

Crespo, Maria M. ;

Bermudez, Christian A. ;

Dew, Mary Amanda ;

Johnson, Bruce A. ;

George, M. Patricia ;

Bhama, Jay ;

Morrell, Matthew ;

D'Cunha, Jonathan ;

Shigemura, Norihisa ;

Richards, Thomas J. ;

Pilewski, Joseph M. .

ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (06) :784-792

[7]

Daoussis D, 2012, CLIN EXP RHEUMATOL, V30, pS17

[8] Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study [J].

Daoussis, Dimitrios ;

Liossis, Stamatis-Nick C. ;

Tsamandas, Athanassios C. ;

Kalogeropoulou, Christina ;

Kazantzi, Alexandra ;

Sirinian, Chaido ;

Karampetsou, Maria ;

Yiannopoulos, Georgios ;

Andonopoulos, Andrew P. .

RHEUMATOLOGY, 2010, 49 (02) :271-280

[9] A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis [J].

Derk, Chris T. ;

Grace, Elizabeth ;

Shenin, Max ;

Naik, Manisha ;

Schulz, Steffan ;

Xiong, Wen .

RHEUMATOLOGY, 2009, 48 (12) :1595-1599

[10] Experience with azathioprine in systemic sclerosis associated with interstitial lung disease [J].

Dheda, K ;

Lalloo, UG ;

Cassim, B ;

Mody, GM .

CLINICAL RHEUMATOLOGY, 2004, 23 (04) :306-309

← 1 2 3 4 5 6 →